Lunit & Agilent partner on AI for precision diagnostics
On October 8, 2025, Lunit (South Korea) and Agilent Technologies announced a collaboration to build AI-based companion diagnostic tools combining Lunit’s algorithms with Agilent’s biomarker assays This effort aims to improve diagnostic accuracy and therapy measurement, especially in oncology. The impact: more personalized treatments and faster drug development cycles.